Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells

Cisplatin (cis-diamminedichloroplatinum) is widely used for the treatment of solid malignancies; however, the development of chemoresistance hinders the success of this chemotherapeutic in the clinic. This study provides novel insights into the molecular and phenotypic changes in an isogenic oesopha...

Descripció completa

Dades bibliogràfiques

Autors principals:	Amy M. Buckley, Becky AS. Bibby, Margaret R. Dunne, Susan A. Kennedy, Maria B. Davern, Breandán N. Kennedy, Stephen G. Maher, Jacintha O’Sullivan
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2019-02-01
Col·lecció:	Pharmaceuticals
Matèries:	oesophageal cancer treatment resistance cisplatin metabolism inflammation radiation
Accés en línia:	https://www.mdpi.com/1424-8247/12/1/33
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!